vs
CHOICE HOTELS INTERNATIONAL INC（CHH）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是CHOICE HOTELS INTERNATIONAL INC的1.8倍（$622.0M vs $340.6M），Royalty Pharma plc净利率更高（34.4% vs 5.9%，领先28.6%），Royalty Pharma plc同比增速更快（4.8% vs 2.3%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -11.5%）
凯悦酒店国际集团（Choice Hotels International）是总部位于美国马里兰州北贝塞斯达的跨国酒店集团，为全球规模最大的酒店连锁企业之一，旗下拥有从高端到经济型的多元酒店品牌。截至2024年末，集团在全球46个国家和地区特许经营近7600家酒店，客房总数超65万间。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CHH vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.8倍
$340.6M
营收增速更快
RPRX
高出2.5%
2.3%
净利率更高
RPRX
高出28.6%
5.9%
两年增速更快
RPRX
近两年复合增速
-11.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $340.6M | $622.0M |
| 净利润 | $20.0M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 17.6% | 62.4% |
| 净利率 | 5.9% | 34.4% |
| 营收同比 | 2.3% | 4.8% |
| 净利润同比 | -54.4% | 2.9% |
| 每股收益（稀释后） | $0.44 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHHRPRX
| Q1 26 | $340.6M | — | ||
| Q4 25 | $390.1M | $622.0M | ||
| Q3 25 | $447.3M | $609.3M | ||
| Q2 25 | $426.4M | $578.7M | ||
| Q1 25 | $332.9M | $568.2M | ||
| Q4 24 | $389.8M | $593.6M | ||
| Q3 24 | $428.0M | $564.7M | ||
| Q2 24 | $435.2M | $537.3M |
净利润CHHRPRX
| Q1 26 | $20.0M | — | ||
| Q4 25 | $63.7M | $214.2M | ||
| Q3 25 | $180.0M | $288.2M | ||
| Q2 25 | $81.7M | $30.2M | ||
| Q1 25 | $44.5M | $238.3M | ||
| Q4 24 | $75.8M | $208.2M | ||
| Q3 24 | $105.7M | $544.0M | ||
| Q2 24 | $87.1M | $102.0M |
营业利润率CHHRPRX
| Q1 26 | 17.6% | — | ||
| Q4 25 | 26.0% | 62.4% | ||
| Q3 25 | 31.8% | 70.1% | ||
| Q2 25 | 29.2% | 36.3% | ||
| Q1 25 | 24.0% | 94.0% | ||
| Q4 24 | 30.6% | 60.9% | ||
| Q3 24 | 35.5% | — | ||
| Q2 24 | 30.5% | 50.2% |
净利率CHHRPRX
| Q1 26 | 5.9% | — | ||
| Q4 25 | 16.3% | 34.4% | ||
| Q3 25 | 40.2% | 47.3% | ||
| Q2 25 | 19.2% | 5.2% | ||
| Q1 25 | 13.4% | 41.9% | ||
| Q4 24 | 19.4% | 35.1% | ||
| Q3 24 | 24.7% | 96.3% | ||
| Q2 24 | 20.0% | 19.0% |
每股收益（稀释后）CHHRPRX
| Q1 26 | $0.44 | — | ||
| Q4 25 | $1.35 | $0.49 | ||
| Q3 25 | $3.86 | $0.67 | ||
| Q2 25 | $1.75 | $0.07 | ||
| Q1 25 | $0.94 | $0.55 | ||
| Q4 24 | $1.56 | $0.46 | ||
| Q3 24 | $2.22 | $1.21 | ||
| Q2 24 | $1.80 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $43.9M | $618.7M |
| 总债务越低越好 | $2.0B | $9.0B |
| 股东权益账面价值 | $137.4M | $9.7B |
| 总资产 | $2.9B | $19.6B |
| 负债/权益比越低杠杆越低 | 14.58× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CHHRPRX
| Q1 26 | $43.9M | — | ||
| Q4 25 | $45.0M | $618.7M | ||
| Q3 25 | $52.6M | $938.9M | ||
| Q2 25 | $58.6M | $631.9M | ||
| Q1 25 | $40.1M | $1.1B | ||
| Q4 24 | $40.2M | $929.0M | ||
| Q3 24 | $58.6M | $950.1M | ||
| Q2 24 | $60.4M | $1.8B |
总债务CHHRPRX
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $9.0B | ||
| Q3 25 | $1.9B | $8.9B | ||
| Q2 25 | $1.9B | $8.0B | ||
| Q1 25 | $1.9B | $7.6B | ||
| Q4 24 | $1.8B | $7.6B | ||
| Q3 24 | $1.8B | $7.6B | ||
| Q2 24 | $1.9B | $7.6B |
股东权益CHHRPRX
| Q1 26 | $137.4M | — | ||
| Q4 25 | $181.2M | $9.7B | ||
| Q3 25 | $149.8M | $9.6B | ||
| Q2 25 | $-26.2M | $9.5B | ||
| Q1 25 | $-63.9M | $9.8B | ||
| Q4 24 | $-45.3M | $10.3B | ||
| Q3 24 | $-96.2M | $10.3B | ||
| Q2 24 | $-146.8M | $9.8B |
总资产CHHRPRX
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.9B | $19.6B | ||
| Q3 25 | $2.9B | $19.3B | ||
| Q2 25 | $2.7B | $18.3B | ||
| Q1 25 | $2.6B | $17.6B | ||
| Q4 24 | $2.5B | $18.2B | ||
| Q3 24 | $2.5B | $18.0B | ||
| Q2 24 | $2.5B | $17.7B |
负债/权益比CHHRPRX
| Q1 26 | 14.58× | — | ||
| Q4 25 | 10.52× | 0.92× | ||
| Q3 25 | 12.81× | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CHHRPRX
| Q1 26 | — | — | ||
| Q4 25 | $85.7M | $827.1M | ||
| Q3 25 | $68.7M | $702.6M | ||
| Q2 25 | $95.6M | $364.0M | ||
| Q1 25 | $20.5M | $596.1M | ||
| Q4 24 | $82.9M | $742.5M | ||
| Q3 24 | $122.9M | $703.6M | ||
| Q2 24 | $111.9M | $658.2M |
自由现金流CHHRPRX
| Q1 26 | — | — | ||
| Q4 25 | $64.1M | — | ||
| Q3 25 | $49.1M | — | ||
| Q2 25 | $65.4M | — | ||
| Q1 25 | $-15.0M | — | ||
| Q4 24 | $57.4M | — | ||
| Q3 24 | $92.6M | — | ||
| Q2 24 | $86.6M | — |
自由现金流率CHHRPRX
| Q1 26 | — | — | ||
| Q4 25 | 16.4% | — | ||
| Q3 25 | 11.0% | — | ||
| Q2 25 | 15.3% | — | ||
| Q1 25 | -4.5% | — | ||
| Q4 24 | 14.7% | — | ||
| Q3 24 | 21.6% | — | ||
| Q2 24 | 19.9% | — |
资本支出强度CHHRPRX
| Q1 26 | — | — | ||
| Q4 25 | 5.5% | — | ||
| Q3 25 | 4.4% | — | ||
| Q2 25 | 7.1% | — | ||
| Q1 25 | 10.7% | — | ||
| Q4 24 | 6.5% | — | ||
| Q3 24 | 7.1% | — | ||
| Q2 24 | 5.8% | — |
现金转化率CHHRPRX
| Q1 26 | — | — | ||
| Q4 25 | 1.35× | 3.86× | ||
| Q3 25 | 0.38× | 2.44× | ||
| Q2 25 | 1.17× | 12.06× | ||
| Q1 25 | 0.46× | 2.50× | ||
| Q4 24 | 1.09× | 3.57× | ||
| Q3 24 | 1.16× | 1.29× | ||
| Q2 24 | 1.28× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHH
| Franchise and management fees | $149.6M | 44% |
| Other | $135.8M | 40% |
| Owned hotels | $30.4M | 9% |
| Partnership services and fees | $24.7M | 7% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
